OptimizeRx CorporationOPRXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-24.3%
5Y CAGR-27.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-24.3%/yr
vs -4.9%/yr prior
5Y CAGR
-27.9%/yr
Recent acceleration
Acceleration
-19.3pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.08 | +115.4% |
| 2024 | 0.97 | -71.8% |
| 2023 | 3.43 | -28.4% |
| 2022 | 4.78 | -72.6% |
| 2021 | 17.46 | +63.7% |
| 2020 | 10.67 | +90.8% |
| 2019 | 5.59 | -4.5% |
| 2018 | 5.85 | +53.5% |
| 2017 | 3.81 | +22.9% |
| 2016 | 3.10 | - |